GVI uses Toshiba’s Spot Fluoroscopy to reduce radiation exposure to patients and physicians

Gates Vascular Institute is now able to conduct safer exams using Spot Fluoroscopy, a cardiovascular X-ray dose management technology from Toshiba America Medical Systems, Inc. GVI utilizes Spot Fluoroscopy with its Infinix^TM-i bi-plane to reduce radiation exposure to both patients and physicians.

"Patients and clinicians are exposed to less radiation, as Spot Fluoroscopy enables our team to focus on the region of interest without radiating the entire area," said Vijay Iyer, M.D., Ph.D., FACC, medical director of cardiology at Kaleida Health and assistant professor of medicine at the University at Buffalo School of Medicine and Biomedical Sciences (UB). "This is beneficial especially in coronary artery, peripheral, electrophysiology and neurological exams, where the field of interest is narrow, but seeing outside this area helps with procedure efficiency."

Spot Fluoroscopy offers a more complete picture while improving safety during interventional procedures. It enhances imaging and manages radiation exposure by providing a live "spot" (customizable field-of-view) of fluoroscopy overlaid onto the Last Image Hold (LIH) display on the exam room monitor.

"Toshiba's collaborations with leading healthcare institutions like GVI allow physicians to use the most advanced technology to provide patients with safer, more effective exams," said David Sloop, director, X-ray Vascular Business Unit, Toshiba.

Toshiba will showcase the Infinix^TM-i with Spot Fluoroscopy at this year's Transcatheter Cardiovascular Therapeutics (TCT) conference, Oct. 27-Nov. 3 in San Francisco.